190 related articles for article (PubMed ID: 37211001)
1. Identification of core therapeutic targets for Monkeypox virus and repurposing potential of drugs against them: An in silico approach.
Sahu A; Gaur M; Mahanandia NC; Subudhi E; Swain RP; Subudhi BB
Comput Biol Med; 2023 Jul; 161():106971. PubMed ID: 37211001
[TBL] [Abstract][Full Text] [Related]
2. Drug repurposing for Mpox: Discovery of small molecules as potential inhibitors against DNA-dependent RNA polymerase using molecular modeling approach.
Dutt M; Kumar A; Rout M; Dehury B; Martinez G; Ndishimye P; Kelvin AA; Kelvin DJ
J Cell Biochem; 2023 May; 124(5):701-715. PubMed ID: 36946432
[TBL] [Abstract][Full Text] [Related]
3. The discovery of novel antivirals for the treatment of mpox: is drug repurposing the answer?
Ezat AA; Abduljalil JM; Elghareib AM; Samir A; Elfiky AA
Expert Opin Drug Discov; 2023 May; 18(5):551-561. PubMed ID: 37032577
[TBL] [Abstract][Full Text] [Related]
4. In silico identification of potential inhibitors of vital monkeypox virus proteins from FDA approved drugs.
Sahoo AK; Augusthian PD; Muralitharan I; Vivek-Ananth RP; Kumar K; Kumar G; Ranganathan G; Samal A
Mol Divers; 2023 Oct; 27(5):2169-2184. PubMed ID: 36331784
[TBL] [Abstract][Full Text] [Related]
5. Computer-assisted drug repurposing for thymidylate kinase drug target in monkeypox virus.
Ajmal A; Mahmood A; Hayat C; Hakami MA; Alotaibi BS; Umair M; Abdalla AN; Li P; He P; Wadood A; Hu J
Front Cell Infect Microbiol; 2023; 13():1159389. PubMed ID: 37313340
[TBL] [Abstract][Full Text] [Related]
6. Repurposing of the antibiotic nitroxoline for the treatment of mpox.
Bojkova D; Zöller N; Tietgen M; Steinhorst K; Bechtel M; Rothenburger T; Kandler JD; Schneider J; Corman VM; Ciesek S; Rabenau HF; Wass MN; Kippenberger S; Göttig S; Michaelis M; Cinatl J
J Med Virol; 2023 Mar; 95(3):e28652. PubMed ID: 36897017
[TBL] [Abstract][Full Text] [Related]
7. Identifying potential monkeypox virus inhibitors: an
Ashley CN; Broni E; Wood CM; Okuneye T; Ojukwu MT; Dong Q; Gallagher C; Miller WA
Front Cell Infect Microbiol; 2024; 14():1351737. PubMed ID: 38500508
[TBL] [Abstract][Full Text] [Related]
8. Targeting the I7L Protease: A Rational Design for Anti-Monkeypox Drugs?
Dodaro A; Pavan M; Moro S
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108279
[TBL] [Abstract][Full Text] [Related]
9. Mpox (formerly monkeypox): pathogenesis, prevention, and treatment.
Lu J; Xing H; Wang C; Tang M; Wu C; Ye F; Yin L; Yang Y; Tan W; Shen L
Signal Transduct Target Ther; 2023 Dec; 8(1):458. PubMed ID: 38148355
[TBL] [Abstract][Full Text] [Related]
10. Molecular docking of monkeypox (mpox) virus proteinase with FDA approved lead molecules.
Arasu MV; Vijayaragavan P; Purushothaman S; Rathi MA; Al-Dhabi NA; Gopalakrishnan VK; Choi KC; Ilavenil S
J Infect Public Health; 2023 May; 16(5):784-791. PubMed ID: 36958173
[TBL] [Abstract][Full Text] [Related]
11. Repurposing Amphotericin B and Its Liposomal Formulation for the Treatment of Human Mpox.
Peruzzu D; Fecchi K; Venturi G; Gagliardi MC
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240241
[TBL] [Abstract][Full Text] [Related]
12. In-silico targeting TMPK from monkey pox virus: Molecular docking analysis, density functional theory studies and molecular dynamic simulation analysis.
Sib Tul Hassan Shah S; Naeem I
J Biomol Struct Dyn; 2023; 41(24):14689-14701. PubMed ID: 36970852
[TBL] [Abstract][Full Text] [Related]
13. A multi-targeted computational drug discovery approach for repurposing tetracyclines against monkeypox virus.
Alandijany TA; El-Daly MM; Tolah AM; Bajrai LH; Khateb AM; Kumar GS; Dubey A; Dwivedi VD; Azhar EI
Sci Rep; 2023 Sep; 13(1):14570. PubMed ID: 37666979
[TBL] [Abstract][Full Text] [Related]
14. Breaking Barriers: Current Advances and Future Directions in Mpox Therapy.
Shah BM; Modi P
Curr Drug Targets; 2024; 25(1):62-76. PubMed ID: 38151842
[TBL] [Abstract][Full Text] [Related]
15. Proteome-Based Investigation Identified Potential Drug Repurposable Small Molecules Against Monkeypox Disease.
Bhattacharjee A; Ahammad I; Chowdhury ZM; Das KC; Keya CA; Salimullah M
Mol Biotechnol; 2024 Apr; 66(4):626-640. PubMed ID: 36357534
[TBL] [Abstract][Full Text] [Related]
16.
Lokhande KB; Shrivastava A; Singh A
J Biomol Struct Dyn; 2023; 41(23):14259-14274. PubMed ID: 36841550
[TBL] [Abstract][Full Text] [Related]
17. Targeted amplification-based whole genome sequencing of
Isabel S; Eshaghi A; Duvvuri VR; Gubbay JB; Cronin K; Li A; Hasso M; Clark ST; Hopkins JP; Patel SN; Braukmann TWA
Microbiol Spectr; 2024 Jan; 12(1):e0297923. PubMed ID: 38047694
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf.
De Clercq E; Jiang Y; Li G
Travel Med Infect Dis; 2023; 52():102528. PubMed ID: 36539022
[TBL] [Abstract][Full Text] [Related]
19. Rapid detection of mpox virus using recombinase aided amplification assay.
Cui X; Du B; Feng J; Feng Y; Cui J; Yan C; Zhao H; Gan L; Fan Z; Fu T; Xu Z; Zhang R; Du S; Zhou Y; Tian Z; Zhang Q; Fu H; Xue G; Yuan J
Front Cell Infect Microbiol; 2023; 13():1008783. PubMed ID: 36909721
[TBL] [Abstract][Full Text] [Related]
20. Detection of Mpox Virus in Seminal Fluids: Implications for Sexual Transmission.
Raccagni AR; Castagna A; Nozza S
New Microbiol; 2024 Jan; 46(4):317-321. PubMed ID: 38252041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
